Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria

The recently revised World Health Organization (WHO) classification of myeloid neoplasms recognizes prefibrotic myelofibrosis (prePMF) as a distinct entity, characterized by well-defined histopathologic features together with minor clinical criteria (leukocytes, anemia, increased LDH, splenomegaly)....

Descripción completa

Detalles Bibliográficos
Autores principales: Rumi, Elisa, Boveri, Emanuela, Bellini, Marta, Pietra, Daniela, Ferretti, Virginia V., Sant’Antonio, Emanuela, Cavalloni, Chiara, Casetti, Ilaria C., Roncoroni, Elisa, Ciboddo, Michele, Benvenuti, Pietro, Landini, Benedetta, Fugazza, Elena, Troletti, Daniela, Astori, Cesare, Cazzola, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731910/
https://www.ncbi.nlm.nih.gov/pubmed/29254200
http://dx.doi.org/10.18632/oncotarget.21594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731910/
https://www.ncbi.nlm.nih.gov/pubmed/29254200
http://dx.doi.org/10.18632/oncotarget.21594

Ejemplares similares